These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12402158)

  • 1. Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects.
    Dredge K; Marriott JB; Macdonald CD; Man HW; Chen R; Muller GW; Stirling D; Dalgleish AG
    Br J Cancer; 2002 Nov; 87(10):1166-72. PubMed ID: 12402158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic and antitumour potential of thalidomide analogues.
    Marriott JB; Muller G; Stirling D; Dalgleish AG
    Expert Opin Biol Ther; 2001 Jul; 1(4):675-82. PubMed ID: 11727503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide derived immunomodulatory drugs (IMiDs) as potential therapeutic agents.
    Marriott JB; Dredge K; Dalgleish AG
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Sep; 3(3):181-6. PubMed ID: 12871024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.
    Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG
    Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide analogs as emerging anti-cancer drugs.
    Dredge K; Dalgleish AG; Marriott JB
    Anticancer Drugs; 2003 Jun; 14(5):331-5. PubMed ID: 12782937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.
    Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G
    J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential new therapeutics for Waldenstrom's macroglobulinemia.
    Zeldis JB; Schafer PH; Bennett BL; Mercurio F; Stirling DI
    Semin Oncol; 2003 Apr; 30(2):275-81. PubMed ID: 12720152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.
    Dredge K; Horsfall R; Robinson SP; Zhang LH; Lu L; Tang Y; Shirley MA; Muller G; Schafer P; Stirling D; Dalgleish AG; Bartlett JB
    Microvasc Res; 2005 Jan; 69(1-2):56-63. PubMed ID: 15797261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells.
    Marriott JB; Clarke IA; Dredge K; Muller G; Stirling D; Dalgleish AG
    Clin Exp Immunol; 2002 Oct; 130(1):75-84. PubMed ID: 12296856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of cytokine production from intestinal lamina propria T cells by phosphodiesterase-4 inhibitory thalidomide analogues.
    Prehn JL; Landers C; Muller GW; Man HW; Stirling DI; Targan SR
    J Clin Immunol; 2001 Sep; 21(5):357-64. PubMed ID: 11720008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide analogs and PDE4 inhibition.
    Muller GW; Shire MG; Wong LM; Corral LG; Patterson RT; Chen Y; Stirling DI
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2669-74. PubMed ID: 9873600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapies targeting the myeloma cell and its bone marrow microenvironment.
    Hideshima T; Chauhan D; Podar K; Schlossman RL; Richardson P; Anderson KC
    Semin Oncol; 2001 Dec; 28(6):607-12. PubMed ID: 11740818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis inhibitors derived from thalidomide.
    Noguchi T; Fujimoto H; Sano H; Miyajima A; Miyachi H; Hashimoto Y
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5509-13. PubMed ID: 16183272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.
    Ng SS; Gütschow M; Weiss M; Hauschildt S; Teubert U; Hecker TK; Luzzio FA; Kruger EA; Eger K; Figg WD
    Cancer Res; 2003 Jun; 63(12):3189-94. PubMed ID: 12810647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer.
    Capitosti SM; Hansen TP; Brown ML
    Bioorg Med Chem; 2004 Jan; 12(2):327-36. PubMed ID: 14723953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation.
    Marks MG; Shi J; Fry MO; Xiao Z; Trzyna M; Pokala V; Ihnat MA; Li PK
    Biol Pharm Bull; 2002 May; 25(5):597-604. PubMed ID: 12033499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of thalidomide and its analogues.
    De Sanctis JB; Mijares M; Suárez A; Compagnone R; Garmendia J; Moreno D; Salazar-Bookaman M
    Recent Pat Inflamm Allergy Drug Discov; 2010 Jun; 4(2):144-8. PubMed ID: 20307255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological effects of thalidomide and its chemical and functional analogs.
    Dredge K; Marriott JB; Dalgleish AG
    Crit Rev Immunol; 2002; 22(5-6):425-37. PubMed ID: 12803319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues.
    Lima LM; Castro P; Machado AL; Fraga CA; Lugnier C; de Moraes VL; Barreiro EJ
    Bioorg Med Chem; 2002 Sep; 10(9):3067-73. PubMed ID: 12110331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Search for new anti-angiogenic agents with structural analogy with thalidomide].
    Vidal M; Gasse C; Garbay C; Galons H
    Ann Pharm Fr; 2005 Jan; 63(1):85-9. PubMed ID: 15803105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.